Ubs Global Asset Management Americas »

Altimmune shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Altimmune (ALT) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Altimmune

Tip: Access up to 7 years of quarterly data

All positions including Altimmune held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Altimmune by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2024-03-31 $185k 18k 10.18
2023-06-30 $81k 19k 4.22
2023-03-31 $81k 19k 4.22
2022-12-31 $900k 55k 16.45

More positions owned by Ubs Global Asset Management Americas

Microsoft Corp Equity Us Cm (MSFT)
Apple Equity Us Cm (AAPL)
Nvidia Corp Equity Us Cm (NVDA)
Amazon Equity Us Cm (AMZN)
Alphabet Inc Cl A Equity Us Cm (GOOGL)
Meta Platforms Equity Us Cm (META)
Ishares Core Msci Eafe Equity (IEFA)
Alphabet Inc Cl C Equity Us Cm (GOOG)
Eli Lilly &#38 Equity Us Cm (LLY)
Broadcom Equity Us Cm (AVGO)
Tesla Equity Us Cm (TSLA)
Unitedhealth Group Equity Us Cm (UNH)
Advanced Micro Devices Equity Us Cm (AMD)
Visa Inc Class A Shares Equity Us Cm (V)
Jpmorgan Chase &#38 Company Equity Us Cm (JPM)

View all positions for Ubs Global Asset Management Americas

Top funds holding Altimmune

State Street Corporation
BlackRock
Vanguard Group
Tang Capital Management
Morgan Stanley
Susquehanna International
Ameriprise Financial
Millennium Management
Geode Capital Management
Fred Alger Management
Nuveen Asset Management
Portolan Capital Management
Rafferty Asset Management
Goldman Sachs Group
Readystate Asset Management

View all funds holding Altimmune